201677-01-2

Basic information

• Product Name: 9-[2-deoxy-2-iodo-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-9H-purin-6-N-triphenylphosphoranylideneamine
• Synonyms: 9-[2-deoxy-2-iodo-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-9H-purin-6-N-triphenylphosphoranylideneamine
• CAS NO: 201677-01-2
• Molecular Weight: 879.925
• Mol File: 201677-01-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 9-[2-deoxy-2-iodo-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-9H-purin-6-N-triphenylphosphoranylideneamine(CAS DataBase Reference)
• NIST Chemistry Reference: 9-[2-deoxy-2-iodo-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-9H-purin-6-N-triphenylphosphoranylideneamine(201677-01-2)
• EPA Substance Registry System: 9-[2-deoxy-2-iodo-3,5-O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]-β-D-arabinofuranosyl]-9H-purin-6-N-triphenylphosphoranylideneamine(201677-01-2)

Safety Data

• Hazardous Substances Data: 201677-01-2(Hazardous Substances Data)

Upstream product

• 58-61-7 adenosine 
• 201677-07-8 9-[2-deoxy-3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-1-C-(2,2-dimethyl-1-oxopropoxy)-2-iodo-β-D-arabinofuranosyl]-9H-purin-6-amine 
• 69304-37-6 1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane 
• 69304-45-6 3',5'-O-(1,1,3,3-tetra-isopropyldisiloxane-1,3-diyl)adenosine 
• 603-35-0 triphenylphosphine 

Relevant articles and documents

Synthesis of {[5-(adenin-9-yl)-2-furyl]methoxy}methyl phosphonic acid and evaluations against human adenylate kinases

AMP mimics constitute an important class of therapeutic derivatives to treat diseases where the pool of ATP is involved. A new phosphonate derivative of 9-(5-hydroxymethylfuran-2-yl)adenine was synthesized in a multi-step sequence from commercially available adenosine. Its ability to behave as a substrate of human adenylate kinases 1 and 2 was assessed. The phosphonate was shown to be a moderate but selective substrate of the mitochondrial human AK2, better than well-known antiviral acyclic phosphonates 9-(2-phosphonomethoxyethyl)adenine (PMEA, Adefovir) and (R)-9-(2-phosphonomethoxypropyl)adenine (PMPA, Tenofovir). Putative binding mode within adenylate kinase NMP site revealed by molecular docking in comparison to AMP native substrate allowed to illustrate this selective behavior.